The vast potential of RNA-based therapies

Workshop in Würzburg brings together renowned scientists

RNA-based vaccines have received considerable public attention due to their pivotal role in combating the COVID-19 pandemic. However, these vaccines represent only one aspect of the many possibilities and research approaches within RNA-based therapies.

At the invitation of the German National Academy of Sciences Leopoldina and the Helmholtz Institute Würzburg, renowned scientists gathered on the Medical Campus from March 18 to 19 to discuss the potential of RNA-based therapies.